Immuron (IMRN) Finished Goods (2017 - 2021)
Immuron (IMRN) posted quarterly Finished Goods of $328833.0 for Q2 2021, down 31.54% year-on-year from $480313.3 in Q2 2020, and down 42.72% on a QoQ basis from $574084.0 in Q4 2020.
Immuron (IMRN) Finished Goods (2017 - 2021) Analysis & Trends
Immuron (IMRN) has reported Finished Goods for 5 consecutive years, with $328833.0 the latest figure, recorded in Q2 2021.
- Quarterly Finished Goods fell 31.54% year-over-year to $328833.0 in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $328833.0 (down 31.54% YoY) and the FY2020 annual result came in at $574084.0, up 18.21% from the prior year.
- Finished Goods slipped to $328833.0 in Q2 2021 per IMRN's latest filing, from $574084.0 in the prior quarter.
- Over the last five years, Finished Goods for IMRN reached as high as $574084.0 in Q4 2020 and fell as low as $126177.0 in Q2 2019.
- A 5-year average of $337209.6 and a median of $297262.5 in 2018 frame the typical range for Finished Goods.
- Annual changes were most pronounced in 2019 — Finished Goods sank 52.51% — and 2020, when it jumped 280.67%.
- Year by year, Finished Goods stood at $357478.0 in 2017, then plunged by 34.06% to $235726.0 in 2018, then jumped by 106.02% to $485641.0 in 2019, then grew by 18.21% to $574084.0 in 2020, then slumped by 42.72% to $328833.0 in 2021.
- According to Business Quant data, Finished Goods over the past three periods registered $328833.0, $574084.0, and $480313.3 for Q2 2021, Q4 2020, and Q2 2020 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Immuron | 270.20 Mn | 258.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 328,833.00 |
| Dec 31, 2020 | 574,084.00 |
| Jun 30, 2020 | 480,313.29 |
| Dec 31, 2019 | 485,641.00 |
| Jun 30, 2019 | 126,177.00 |
| Dec 31, 2018 | 235,726.00 |
| Aug 30, 2018 | 265,692.00 |
| Jun 30, 2018 | 265,692.00 |
| Dec 31, 2017 | 357,478.00 |
| Jun 30, 2017 | 252,459.78 |